StockNow
Log in
U.S. Markets

Thermo Fisher Scientific (TMO) Q2 2026 (USD): Revenue 12bln (exp. 11.7bln), adj. EBIT 2.73bln (exp. 2.59bln), adj. EPS 6.03 (exp. 5.72)

StockNow breaking-news AI analysis

Thermo Fisher Scientific surpassed Q2 2026 expectations across revenue, adjusted EBIT, and adjusted EPS, reporting $12 billion in revenue and $6.03 in adjusted EPS today.

1 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
U.S. Markets

Eli Lilly (LLY) Q2 2026 (USD): Adj. EPS 8.38 (exp. 6.01), Revenue 23bln (exp. 20.7bln)

LLYGeopolitics

Pakistani sources say Pakistan PM Sharif and Army Chief Munir will visit Saudi Arabia tomorrow, Al Hadath reports

U.S. Economy

US ADP Employment Change (Jul) 44K vs. Exp. 70K (Prev. 98K)